Objectives to assess if ubiquitinated proteins potentially present in neutrophil extracellular traps (nEts) can modify cellular responses and induce inflammatory mechanisms in patients with systemic lupus erythematosus (SLE) and healthy subjects. Materials and methods We studied 74 subjects with SLE and 77 healthy controls. neutrophils and low-density granulocytes were isolated, and nEts were induced. Ubiquitin content was quantified in nEts by western blot analysis, ELISA and immunofluorescence microscopy, while ubiquitination of nEt proteins was assessed by immunoprecipitation. Monocyte-derived macrophages from SLE and controls were isolated and stimulated with nEts or ubiquitin. Calcium flux and cytokine synthesis were measured following these stimuli.
IntrOductIOn
Neutrophil extracellular traps (NETs) are extracellular fibres primarily composed of nucleic acids bound to neutrophil granule-derived proteins. 1 The process of NET formation (NETosis) has recently been associated with the pathogenesis of systemic lupus erythematosus (SLE), since it causes the exposure of modified (oxidised) extracellular DNA. 2 3 Increased NET formation occurs in SLE, in particular mediated by low-density granulocytes (LDGs), a proinflammatory neutrophil subset increased in patients with lupus. 4 In addition, an impaired NET degradation has been described in SLE, promoting an imbalance that prolongs the half-life of NET components. 5 6 Macrophages, which have been found to be defective in phagocytosing autoantigens in patients with SLE, 7 are involved in NET clearance. 8 While NET degradation by macrophages has not been found to be proinflammatory in healthy subjects, 8 the process has not been studied in patients with SLE.
Post-translational modifications (PTMs) can alter protein structure and function. Different NET components, such as histones, are susceptible to undergo PTMs (ie, acetylation, citrullination). 9 10 Ubiquitination is a PTM that has typically been associated with protein degradation, but it can also impact many cellular processes by modifying protein function and gene transcription. [11] [12] [13] In patients with SLE, defects in ubiquitination have been proposed to promote loss of peripheral tolerance. 14 Furthermore, extracellular ubiquitin has been recently described as an immune system regulator in diverse conditions. [15] [16] [17] [18] When extracellular ubiquitin binds its receptor, CXCR4, 19 a signalling cascade promotes numerous intracellular processes, including increases in calcium flux. 19 20 Since NET proteins may be the target of different PTMs and ubiquitination is associated with immune tolerance, it is relevant to address whether NETs from patients with SLE are differentially ubiquitinated, in order to analyse the implications of this process in the immune dysregulation characteristic of this disease. Therefore, the aim of this study was to evaluate the potential role of ubiquitination in inflammatory responses triggered by NETs in patients with SLE and healthy controls.
MethOds
For full methods, see online supplementary text.
Patients and controls
We included 74 subjects with SLE, who fulfilled ≥4 American College of Rheumatology (ACR) 21 classification criteria and had different levels of disease activity according to the SLEDAI score, 22 as well as 77 healthy controls. All subjects signed informed consent. 
results
Most subjects were women (89%), with a mean age of 32±11 years. Fifty-nine subjects with SLE (78.6%) had a SLEDAI score ≥6. Most patients (64%) did not have any immunosuppressive treatment at the time of the blood draw. The most common disease activity at the time of inclusion was renal (68%). SLE-associated variables are shown in online supplementary table S1. Numbers and main characteristics of patients included for each experiment are shown in online supplementary table S2. Confirming previous results, when measured by Sytox green, lupus neutrophils had an increased NET synthesis compared with controls (P<0.001).
nets contain ubiquitinated proteins and sle nets display lower K63-mediated polyubiquitination
Ubiquitin was detected in NETs of both patients with SLE and controls by immunofluorescence microscopy (figure 1). In order to confirm these results, an ELISA was performed to detect ubiquitin present in NETs. After analysing NETs from control normal-density granulocytes (NDGs) and lupus NDGs and LDGs, we found a lower ubiquitin concentration in NETs derived from SLE neutrophils compared with healthy controls (P<0.05). NETs from lupus LDGs had the lowest amounts of ubiquitin (P<0.01 vs healthy controls, P<0.05 vs SLE NDGs; figure 2), suggesting that NETs produced by cells with a higher proinflammatory capacity 3 have less ubiquitinated protein cargo. Furthermore, ubiquitinated proteins, specifically polyubiquitinated through lysine 48 and lysine 63, were detected by western blot analysis in both NETs from subjects with SLE and healthy controls (figure 3). A differential ubiquitination pattern was found between subjects with SLE and healthy controls by western blot analysis, with a lower expression of K63 polyubiquitinated proteins in subjects with SLE (P<0.05), as shown in figure 3A . There was also a trend for significant differences in diminished expression of K48 polyubiquitinated proteins in lupus NETs compared with controls (P=0.065, figure 3B ). We did not find a significant difference in the ubiquitin content in NETs (P=0.124) in patients under immunosuppressive treatment in comparison to those untreated. Overall, these results indicate that ubiquitinated proteins are detected in NETs and that lupus and control NETs display different ubiquitination patterns.
Antibody responses to ubiquitinated net proteins develop in patients with sle
After demonstrating the presence of ubiquitinated proteins in NETs, we searched for specific NET components that could be ubiquitin targets. We specifically focused on myeloperoxidase (MPO) because it is a major component of NETs, 23 and because it has an antigenic role in certain autoimmune diseases. Using immunoprecipitation assays, we detected ubiquitinated MPO in NETs from subjects with SLE and controls (see online supplementary figure S2).
In order to determine if adaptive immune responses develop to ubiquitinated MPO (Ub-MPO), sera from patients with SLE and healthy controls was analysed by ELISA to detect antibodies against Ub-MPO and non-Ub-MPO. For this assay, we included Figure 1 Ubiquitin is expressed in neutrophil extracellular traps (NETs) from patients with systemic lupus erythematosus (SLE) and healthy controls. Immunofluorescence of NETs from a representative patient with SLE (A) and a representative healthy control (B), analysed with confocal microscopy; red represents neutrophil elastase, blue represents DNA and green represents ubiquitin. Images positive for neutrophil elastase and nuclear stain, with a characteristic morphology, were classified as NETs. A representative image is shown, demonstrating colocalisation of ubiquitin with the other NET components (B); NIH ImageJ2 software analysis with the colocalisation RGB plugin was performed to find colocalised pixels in red, green and blue channels. Results are displayed in black and white; white represents the merged image of the three channels.
Figure 2
Differential ubiquitin concentration in neutrophil extracellular traps (NETs) from control and lupus normal-density granulocytes (NDGs) and lupus low-density granulocytes (LDGs). ELISA for total ubiquitin in NETs from healthy control neutrophils (Ctrl-NETs), lupus NDGs (systemic lupus erythematosus (SLE)-NETs) and lupus LDGs (LDG-NETs) (n=5 subjects per group). Bars represent mean±SEM of ubiquitin concentration in NETs from each group of subjects. **P<0.01, ***P<0.001.
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sera from 57 subjects with SLE and55 healthy controls. Considering the established cut-off value described in the 'Methods' section in online supplementary text, 21% of patients with SLE had antibodies against Ub-MPO, and 14% had antibodies against non-Ub-MPO, whereas only 3.6% and 1.8% of healthy controls had antibodies against both ubiquitinated and native MPO molecules, respectively. When compared with controls, patients with SLE displayed significantly increased titres of anti-Ub-MPO by a normalised optical density (OD) index (2.17 vs 1.26, P=0.0008), as well as antinative MPO antibodies (1.89 vs 1, P=0.001). Furthermore, when comparing antibodies against ubiquitinated and native MPO proteins, there was a higher concentration against Ub-MPO in subjects with SLE (2.17 vs 1.89, P<0.0001; figure 4).
Anti-Ub-MPO antibody levels positively correlated with SLEDAI (r=0.44, P<0.01), and negatively with complement components (C3: r=−0.474, P<0.01; C4: r=−0.426, P<0.01), while no correlation with anti-dsDNA antibody levels was found (P=0.43). Moreover, patients with positive anti-Ub-MPO titres had a higher mean SLEDAI score (17.8 vs 9.58, P=0.022) and a higher frequency of vasculitis (P=0.03) compared with those with negative anti-Ub-MPO antibodies. Overall, these results suggest that patients with lupus, especially those with high disease activity, mount antibody responses to ubiquitinated NET components.
the activation of cXcr4, the receptor for extracellular ubiquitin, causes an increase in calcium flux Extracellular ubiquitin is a natural CXCR4 agonist, and this axis is involved in various CXCR4-mediated cellular processes. 19 As NETs externalise ubiquitin, and subjects with SLE and controls display different ubiquitination patterns in NETs, we assessed the role of ubiquitin and NETs on macrophage responses in the presence and absence of a CXCR4 inhibitor. When macrophages were stimulated with recombinant extracellular ubiquitin, there was a trend for an increase in basal calcium flux, which significantly diminished in the presence of a CXCR4 inhibitor (AMD 3100) (figure 5A). When SLE and control macrophages were stimulated with NETs from control or SLE NDGs or from SLE LDGs, increased calcium flux was also triggered, and it similarly decreased in the presence of a CXCR4 inhibitor ( figure 5C and D) . These results suggest that there is activation of CXCR4 by ubiquitin in NETs. When the response from SLE macrophages was evaluated, the largest increase in calcium flux was observed with control NETs, while the lowest increase occurred with LDG NETs (figure 5B). These findings correlated with the ubiquitin concentration gradient found by ELISA in NETs. We did not find significant differences in calcium flux when macrophages were stimulated with NETs derived from neutrophils exposed to PYR-41 (E1 inhibitor). This finding could be related to inability to completely remove ubiquitin in NETs (see online supplementary figure S3). Overall, these results suggest that ubiquitinated proteins are one of the NET components able to modify calcium flux in macrophages.
Macrophages internalise nets and this process is proinflammatory in sle
Monocyte-derived macrophages from subjects with SLE and controls were cultured in the presence of NETs, and internalised Western blot analysis of NETs from patients with SLE and controls was performed, and quantification was done by densitometry (n=20 subjects per group). Representative blots are included for both types of ubiquitin conjugation profile. Results are expressed as mean±SEM. There was less expression of K63-dependent (A) and K48-dependent (B) polyubiquitinated proteins in SLE NETs than in healthy control NETs. **P<0.01. NET components after 6 hours incubation (ie, as assessed by neutrophil elastase, which is not expressed by macrophages ( figure 6A) ). In order to address whether the internalisation of lupus NET components is a proinflammatory process in macrophages, 8 macrophage supernatants were examined for cytokine release (tumour necrosis factor (TNF)-α, interleukin (IL)-6 and IL-10) after exposure to NETs from subjects with SLE (n=18). In SLE macrophages, TNF-α and IL-10 release was enhanced following stimulation with lipopolysaccharide (LPS)-induced NETs, when compared with the effect observed in control macrophages (P<0.05; figure 6B-D) . There was also a trend towards an increased IL-6 synthesis by SLE macrophages in response to NETs. This differential cytokine profile between patients with SLE and controls was not found after stimulation with spontaneous NETs or LPS alone (data not shown). Finally, we also used chloroquine, mainly as a toll like receptor (TLR) antagonist, 24 25 as well as a NET internalisation inhibitor. 26 We found that SLE macrophages that were pretreated with chloroquine showed a decrease in IL-6 and TNF-α synthesis, but not IL-10, after NET stimulation (P<0.01 and P<0.05, respectively; figure 6B-D) . Besides, on CXCR4 inhibition, macrophages from controls had a decrease in TNF-α (P=0.027) and IL-10 (P=0.012) production ( figure 6B-D) . We found no significant effect of CXCR4 inhibition on cytokine production from lupus macrophages, which could be related to the dysregulation and higher expression of CXCR4 in patients with SLE. 27 These findings suggest that NET internalisation by macrophages is not a silent process, at least in lupus macrophages, and that extracellular ubiquitin-CXCR4 pathway may be partially implicated in cytokine induction triggered by NET internalisation. These results also suggest that chloroquine interferes with NET internalisation by lupus macrophages.
dIscussIOn
Several groups have proposed that NETs play pathogenic roles in SLE. 28 29 Therefore, characterising the role of specific NET modifications and their potential immunogenicity is fundamental in understanding how NETs can promote immune dysregulation and tissue damage. To our knowledge, we now describe for the first time that there are ubiquitinated proteins in NETs, as well as the ubiquitination of myeloperoxidase, one of the most abundant NET proteins.
We found polyubiquitinated proteins in NETs, which could have diverse implications in the immune system. Specifically, K63 ubiquitination is involved in DNA repair, signalling through nuclear factor-κB, and endosomal traffic regulation, all of which are related to the modulation of immune responses. 30 Also, we found decreased ubiquitination in NETs from subjects with SLE compared with controls. Indeed, LDG NETs had the lowest expression of ubiquitinated proteins. This could be related to the lower expression of ubiquitin ligases in SLE, as demonstrated with Cbl-b in lymphocytes. 14 Regarding the effect that this differential ubiquitin expression in NETs may have, extracellular ubiquitin has been associated with a predominantly 
lupus normal density granulocytes and lupus low-density granulocytes (LDGs) (B-D). In addition, a CXCR4 (extracellular ubiquitin receptor) inhibitor was used (A, C, D). Calcium flux was measured by Fluo-4 NW Calcium Assay Kit in all cases (five independent experiments). Calcium flux was enhanced by recombinant ubiquitin (A) and by NETs (B-D)
, and significantly decreased when a CXCR4 inhibitor was added. There was also a differential calcium influx in response to NETs from healthy controls, patients with SLE and LDGs. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001; ns, non-significant. Ctrl-NETs, NETs obtained from healthy controls; SLE-NETs, NETs obtained from normal density granulocytes from patients with SLE; LDG-NETs, NETs obtained from low-density granulocytes from patients with SLE.
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anti-inflammatory and counter-regulatory response in sepsis and other diseases. 15 31 Therefore, its higher levels in healthy control NETs could constitute a regulatory mechanism to dampen the proinflammatory environment that initially leads to NETosis. This mechanism could be absent or deficient in patients with SLE. Furthermore, K63 ubiquitination has been found to play an important role in cellular resistance to oxidative stress. 32 The fact that NETs from patients with SLE have less K63 polyubiquitination could lead to a higher oxidative damage in the context of NETosis. This, in turn, could contribute to endothelial damage and the proatherogenic phenotype in patients with SLE. 33 We also found that NETs contain ubiquitinated MPO. This enzyme seems to play a dual role in inflammation and autoimmunity. Particularly in SLE, it has been associated with enhanced atherosclerosis, 33 as well as with nephritis, 5 29 through the role it plays within NETs. However, a decreased renal inflammation has also been described in MPO deficient mice. 34 We found MPO might induce a humoral response in subjects with SLE, characterised by the production of more autoantibodies against both native and Ub-MPO molecules than healthy controls. The frequency of anti-native MPO antibodies in our study agrees with previous reports in SLE 35 36 and this is the first description of anti-Ub-MPO antibodies. Furthermore, patients with SLE had a higher concentration of anti-Ub-MPO antibodies in comparison to non-Ub-MPO. Since ubiquitin is a highly conserved and very abundant protein, it has been hypothesised that it is unlikely to elicit an immune response and could even protect its substrates from immune recognition. 37 However, by masking certain epitopes, it could expose other, more immunogenic, peptides. It has been reported in a murine model that T cells specific for the PTM variant of a self-antigen are able to escape central tolerance and could provide help to B cells and promote pathogenic autoimmune responses. 38 Also, specifically regarding MPO, ubiquitination could be involved in its dual function in immunity, since this PTM may influence its function, its enzymatic action and its oxidative capacity, both intracellularly and as a NET component. MPO ubiquitination could have a direct impact on tissue injury due to oxidative stress, and on the effect MPO has in other immune cells. Interestingly, MPO has been found to suppress dendritic cells, whereas in its enzymatically inactive form, it can activate lung macrophages. 34 39 Whether these interactions could be affected by ubiquitination remains to be defined.
We found a trend towards a higher macrophage calcium flux when we stimulated these cells with ubiquitin. This effect seems to be mediated by CXCR4, since its stimulation has been described to enhance calcium flux 19 in other biologic systems, and after its inhibition, calcium flux decreased significantly. When macrophages were stimulated with NETs, the highest calcium flux was observed with NETs derived from controls, which had the higher ubiquitin concentration, suggesting that this differential effect may be driven by ubiquitin. To dissect the precise role of ubiquitin from NETs in the enhanced calcium flux, we used NETs from PYR-41-exposed neutrophils, which is a E1-activating enzyme inhibitor. 40 We found no significant differences when comparing with non-PYR-41-exposed neutrophils. This could be secondary to the inability to attain complete removal of ubiquitin in NETs. Current available techniques are directed mainly at blocking the elongation of the ubiquitin chain, rather than removing the first Figure 6 Systemic lupus erythematosus (SLE) macrophages internalise neutrophil extracellular traps (NETs) and synthesise cytokines in response to NET internalisation. Monocyte-derived macrophages from subjects with SLE and healthy subjects were incubated with 50 µg of normal-density granulocytes NETs from subjects with SLE for 6 hours (n=18). (A) Immunofluorescence was performed and analysed by confocal microscopy. Red represents neutrophil elastase and blue represents DNA. A representative image is shown, demonstrating internalisation of neutrophil elastase from NETs by macrophages. (B-D) Supernatants were obtained, and cytokine levels (tumour necrosis factor (TNF)-α, interleukin (IL)-6 and IL-10) were measured by ELISA. Boxes show the pooled data (mean and SEM) of each cytokine assessed in non-stimulated (NS) SLE and control macrophages, macrophages stimulated with NETs, macrophages stimulated with NETs after chloroquine pretreatment and macrophages stimulated with NETs after treatment with a CXCR4 inhibitor (AMD3100). There was a higher TNF-α and IL-10 synthesis in SLE macrophages compared with controls when they were stimulated with NETs. When SLE macrophages were pretreated with chloroquine, IL-6 and TNF-α release significantly decreased. After CXCR4 inhibition, there was a decrease in TNF-α and IL-10 synthesis in control macrophages. *P<0.05; **P<0.01; ***P<0.001.
ubiquitin molecule conjugated to the protein substrate. Most of these techniques were developed for polyubiquitin chain removal in a single protein substrate and are not suitable for a mixture of proteins prone to ubiquitination, such as those present in NETs. 41 Therefore, we consider that the lack of significant differences in the calcium flux are related to the limitation of the current technology available for the assessment of ubiquitination in NETs and to the lack of knowledge of the ubiquitin code (E1, E2, E3 ligases, deubiquitination enzymes, 42 ubiquitin like proteins 43 and non-conventional ubiquitin linkages) 44 that guides ubiquitination during NETosis, a limitation of the present work. Overall, our findings partly support the role of ubiquitin in NETs as a trigger for calcium flux in macrophages, but do not allow us to conclude that it is the only NET component involved in this response. It will be relevant to determine if the concentration of ubiquitin in NETs makes them more or less immunogenic, which could be related to the specific ubiquitinated protein cargo and the lysine residue to which ubiquitin is anchored.
When SLE macrophages were stimulated with NETs, they were internalised and cytokine synthesis was documented. There was a higher synthesis of TNF-α and IL-10 by SLE macrophages compared with control macrophages after they were stimulated with LPS-induced NETs. This partially agrees with the findings by Farrera and Fadeel, who described a higher cytokine synthesis after stimulating with both LPS and NETs than with NETs alone. 8 These results with LPS may be secondary to a synergistic mechanism, which could be mediated by TLR4, a receptor that has been involved in SLE physiopathology. 25 45 46 Of note, pretreatment with chloroquine decreased TNF-α and IL-6 production in SLE macrophages. Chloroquine has been described to specifically alter macrophage IL-6 and TNF-α synthesis through TLR inhibition. 24 Macfarlane and Manzel found that antimalarials inhibit IL-6 synthesis after TLR-9 stimulation, but did not have an effect on LPS-induced responses, 24 which was confirmed by Cepika et al. 47 Furthermore, we recently found that in rheumatoid arthritis synovial fibroblasts can internalise NETs and increase cytokine synthesis, and that NET internalisation is inhibited by antimalarials. 26 This effect was not replicated in the case of IL-10, which could be partly explained by the other pathways involved in the synthesis of this cytokine, 48 and could also be related to its specific role in SLE. Although it is typically regarded as an anti-inflammatory cytokine, high levels of IL-10 have been described in lupus 49 50 and it has even been considered as a disease activity biomarker. 51 Finally, control macrophages displayed decreased TNF-α and IL-10 synthesis after CXCR4 inhibition, which could implicate the ubiquitin-CXCR4 pathway in this process, since ubiquitin has been found to regulate TNF-α and IL-10, 15 but not IL-6 52 synthesis. We did not find similar changes in lupus macrophages, but this could be related to the abnormally enhanced expression and dysregulation of CXCR4 that has been reported in patients with SLE, 27 53 54 which could have led to an incomplete inhibition of this pathway. Also, CXCR4 has a complex recycling process, 55 which could influence the effect of its inhibition in cytokine synthesis, without altering its effect on the initial calcium flux. Our data suggest that NET internalisation by lupus macrophages is not a silent process and may contribute to inflammation in this disease.
In summary, this is the first study that demonstrates the presence of polyubiquitinated proteins in NETs, with a differential profile between patients with SLE and healthy controls. MPO was found to be ubiquitinated in NETs and our data suggest it is a target of humoral responses in SLE. Furthermore, ubiquitin present in NETs is one of the components that regulates calcium flux in macrophages through CXCR4 signalling. Lupus macrophages synthesise inflammatory cytokines in response to NET internalisation, a process that could be partly mediated by TLR-4 and TLR-9. Overall, abnormalities in mechanisms involved in NET internalisation and the extracellular ubiquitination pathway could play important roles in the development of inflammatory responses in SLE.
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